Actively Recruiting
Randomized Study of Oral Bisacodyl Bowel Preparation to Prevent Catheter Dysfunction in Peritoneal Dialysis Patients
Led by Chinese University of Hong Kong · Updated on 2026-10-21
398
Participants Needed
6
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
This trial is focused on patients who require peritoneal dialysis and need a catheter inserted for the procedure. Researchers are investigating whether using a laxative before the catheter insertion can help reduce the risk of catheter flow problems, which can occur in 12% to 31% of patients. The study aims to see if preventive laxative use improves catheter function and reduces the need for intervention. Participants are randomly assigned to one of two groups one group receives oral bisacodyl 5 mg at bedtime for two days before catheter insertion, and the other group receives usual care without additional laxatives. This is an open-label, multi-center study designed to compare laxative bowel preparation versus usual care in preventing catheter dysfunction after insertion. During the study, participants are monitored for catheter dysfunction within 4 weeks of insertion, which is the primary outcome. Secondary outcomes include catheter survival and early peritonitis rates assessed up to 3 months after insertion. Participants will be followed through these periods to evaluate the effects of the laxative preparation. The study is expected to enroll about 199 patients in each group and will continue until September 2027.
CONDITIONS
Brief Title
Bisacodyl Oral for Lowering Dysfunction (of Tenckhoff Catheter)
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here